NCT04606134View on ClinicalTrials.gov

Tripeptide/Hexapeptide Topical and Hybrid Laser Treatment for Acne Scarring

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 13, 2020

Primary Completion Date

June 18, 2021

Study Completion Date

June 18, 2021

Conditions
Acne Scars - Mixed Atrophic and Hypertrophic
Interventions
DEVICE

Hybrid fractional laser

two treatments given one month apart

OTHER

Alastin Regenerating Skin Nectar with TriHex Technology

applied twice daily

OTHER

Cetaphil face cream

applied twice daily

Trial Locations (1)

14642

University of Rochester Medical Center, Rochester

All Listed Sponsors
lead

University of Rochester

OTHER

NCT04606134 - Tripeptide/Hexapeptide Topical and Hybrid Laser Treatment for Acne Scarring | Biotech Hunter | Biotech Hunter